Most Recent
Opal Tower class action defendants banned from contacting group members about settlement
The defendants in the Sydney Opal Tower class action have been formally banned from contacting represented group members about their claims while the proceeding remains on foot, after communications were allegedly sent to apartment owners.
Facing Deloitte cross-claims, Dick Smith execs drag other directors into class action
Former Dick Smith executives Nick Abboud and Michael Potts have pointed the finger at the defunct electronics retailer's other directors in response to cross claims by auditor Deloitte, which is named in two shareholder class actions over the company's collapse.
NSW government points finger at developer in Opal Tower class action
The NSW government's Sydney Olympic Park Authority, which is facing a class action brought by owners of apartments at the troubled Opal Tower, has laid the blame on the developer, designer and builder behind the project.
Battle ahead as Hanwha seeks to ‘strengthen’ solar patent after suing rivals for infringement
Global solar panel manufacturer Hanwha Q CELLS wants to amend the patent behind its solar technology, more than six months after launching infringement proceedings against three rivals.
Wyeth loses privilege claim over Allens docs in Merck’s vaccine patent case
Wyeth has lost a bid to claim legal professional privilege over certain documents sought by Merck Sharp & Dohme as the two rivals head towards a hearing for the reopening of the Prevnar 13 patent case.
‘Serious questions’ raised over conduct of lawyers, funder behind Banksia class action, judge says
A judge overseeing a settled class action against failed Banksia Securities has rejected an application to limit a contradictor's investigation of alleged professional misconduct on the part of the legal team and funder behind the case, saying he was satisfied there was a proper basis for the allegations.
After questioning funder’s cut, judge quietly approves KPMG class action settlement scheme
A judge has quietly given his seal of approval to a settlement distribution scheme in a class action against KPMG, after raising questions about Piper Alderman's legal bill and the litigation funder's "arguably excessive" cut of the confidential settlement.
Otsuka ‘deliberately’ withheld information from court, Generic Health claims
Pharmaceutical company Generic Health has told the Federal Court that, on advice from their solicitors, Otsuka and Bristol-Myers Squibb "deliberately" chose not to disclose their reasons for an admission in a long-running patent case over the anti-psychotic drug Abilify, which they are now seeking to withdraw.
Sportsbet wants BetEasy trade marks removed for non-use
Bookmaker Sportsbet has expanded its case over rival BetEasy's attempts to operate under the 'Sportingbet' trade mark, arguing its marks should be revoked for non-use.
Twin Quintis class actions squabble about ‘overly complicated’ case
The plaintiffs in one of two shareholder class actions brought against troubled sandalwood producer Quintis have complained about potential delays that could result from the “overly complicated loss theory” being advanced in a parallel class action.